Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CTNMCTNM
6 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CONTINEUM THERAPEUTICS INC

CITADEL ADVISORS LLC holds 396,354 shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $6.5M as of 2026-Q2. The position was increased (+13.2% shares). CTNM represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$6.5M

Current Shares

396,354

Total Value Change

+$4.2M

Total Shares Change

+268,569

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
396,354
+13.2%
$6.5M0.0%$16.39
31
2026-Q1
New
350,200
-
$4.6M0.0%$14.10
37
2025-Q3
Exited
0
-100.0%
$00.0%$11.82
0
2025-Q2
New
16,489
-
$65,4610.0%$4.11
32
2024-Q3
Exited
0
-100.0%
$00.0%$18.84
0
2024-Q2
New
127,785
-
$2.3M0.0%$17.61
36

Other major holders of CTNM: Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN RESOURCES INC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used